Invention Grant
US09109007B2 MHC-I restricted epitopes containing non-natural amino acid residues
有权
MHC-1限制含有非天然氨基酸残基的表位
- Patent Title: MHC-I restricted epitopes containing non-natural amino acid residues
- Patent Title (中): MHC-1限制含有非天然氨基酸残基的表位
-
Application No.: US13817261Application Date: 2011-08-18
-
Publication No.: US09109007B2Publication Date: 2015-08-18
- Inventor: Donald J. Kyle , Daniel A. Soltis , Lynda G. Tussey
- Applicant: Donald J. Kyle , Daniel A. Soltis , Lynda G. Tussey
- Applicant Address: US CT Stamford
- Assignee: Purdue Pharma L.P.
- Current Assignee: Purdue Pharma L.P.
- Current Assignee Address: US CT Stamford
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- International Application: PCT/IB2011/001909 WO 20110818
- International Announcement: WO2012/023033 WO 20120223
- Main IPC: A61K38/08
- IPC: A61K38/08 ; C07K4/00 ; C07K7/06 ; C07K14/47 ; C12N9/02 ; C12N9/12 ; G01N33/50 ; G01N33/68 ; A61K39/00

Abstract:
The invention provides for the synthesis of more effective generators of a T-cell immune response by providing peptide derivatives that are MHC class I-restricted antigens. The peptide derivatives of the present invention are prepared or derived from a parent peptide of 8 to 11 amino acid residues in length, wherein the peptide derivative contains a non-natural amino acid substituted in place of a naturally-occurring amino acid residue at one or more primary anchor positions in the parent peptide or at position 6, position 7, or the C-terminus. The exemplary polypeptides are derived from the survivin, hTERT, CYP1B1 and MART-1 antigens.
Public/Granted literature
- US20140050749A1 MHC-I Restricted Epitopes Containing Non-Natural Amino Acid Residues Public/Granted day:2014-02-20
Information query
IPC分类: